On Demand Webinar

Discover how cutting-edge multi-omics approaches and Generative AI are reshaping oncology drug discovery. This webinar, led by Michael Ritchie, PhD, MBA, explores how to decode complex tumor cell biology using multi-dimensional deep datasets for biomarker and target discoveries. It is designed for drug discovery scientists, omics researchers, and pharmaceutical professionals eager to stay at the forefront of innovation and accelerate their research.

Unlock the future of multi-omics in drug discovery!

Key Topics:

• Understand why multi-dimensional deep datasets are critical for biomarker and target discovery.
  
  
• Learn how to leverage baseline and functional profiling data to deepen insights into tumor cell biology.
  
  
• Explore how Generative AI modules, combined with deep datasets, are transforming the drug discovery landscape.
  
  

Meet Our Presenter:

Michael Ritchie, PhD, MBA, Chief Commercial Officer

Michael Ritchie, PhD, MBA joined Champions Oncology in July of 2014 and currently serves as Chief Commercial Officer, overseeing all aspects of commercial development, sales and marketing. Prior to joining Champions, he worked in the oncology research unit at Pfizer, managing therapeutic development programs in the antibody-drug conjugate space and developing novel therapeutic antibody programs. Dr. Ritchie received an MBA from New York University, a doctorate in biochemistry from Temple University School of Medicine, and served a postdoctoral fellowship in Neuroscience at Harvard Medical School.